Therorna
Suzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An RNA therapeutics company creating novel mRNA vaccines and drugs for infectious diseases.
Infectious DiseaseVaccines
Technology Platform
Proprietary mRNA platform featuring optimized lipid nanoparticle delivery systems and nucleoside modifications for enhanced stability and efficacy.
Opportunities
Expanding the mRNA platform to address a broad spectrum of infectious diseases with high unmet need.
Risk Factors
Dependence on a single technology platform and fierce competition from well-capitalized global rivals.
Competitive Landscape
Operates in the highly competitive global mRNA arena, competing with giants like BioNTech but with a focus on the Chinese and Asian markets.